Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00254423
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2005-11-14
Brief Title:
Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Philadelphia Chromosome Positive BCR-ABL1 Positive Chronic Myelogenous Leukemia |
| Chronic Phase Chronic Myelogenous Leukemia BCR-ABL1 Positive |
Keywords: